Following a full submission
AWMSG advice |
||
| Status: Not recommended | ||
The Minister for Health & Social Services has endorsed AWMSG's recommendation that: The use of liposomal cytarabine (DepoCyte®) should not be supported in NHS Wales for the treatment of lymphomatous meningitis. |
||
|
||
Medicine details |
||
| Medicine name | liposomal cytarabine (DepoCyte®) | |
| Formulation | 50 mg suspension for injection | |
| Reference number | 187 | |
| Indication | Intrathecal treatment of lymphomatous meningitis |
|
| Company | Napp Pharmaceuticals Ltd | |
| BNF chapter | Malignant disease & immunosuppression | |
| Submission type | Full | |
| Status | Not recommended | |
| AWMSG meeting date | 06/12/2005 | |
| Ratification by Welsh Government | 28/02/2006 | |
| Date of issue | 28/02/2006 | |